TWH204-President Trump Participates in a Health Care Affordability Event - The White House

In a landmark announcement, President Trump reveals historic reductions in prescription drug prices, transforming the landscape of American healthcare. The event highlights Regeneron's groundbreaking commitment to affordability, with drugs now available at most favored nation prices—a move that promises to lower costs by unprecedented margins. Notably, Regeneron's latest gene therapy, Otarme, is poised to change lives by curing a rare disease that causes deafness, demonstrated through the emotional story of two-year-old Travis Smith, whose life has been radically altered thanks to this treatment. Echoing the sentiments of Secretary Robert F. Kennedy Jr. and Dr. Mehmet Oz, Trump emphasizes the need for these long-awaited price drops, which target chronic unfairness in a system where Americans have historically borne the brunt of soaring pharmaceutical costs. With discounts reaching up to 600%, the announcement underscores the administration's resolve to secure the lowest prices globally for American patients. The event showcases not only the stark realities of current drug pricing but also the strides being taken to realign the pharmaceutical landscape in favor of affordability and accessibility. Join us as we explore the implications of this policy shift and hear from families directly benefitting from these life-changing innovations, reflecting a bold new approach to healthcare in America.

Categories: News